Cormorant Asset Management’s Juno Therapeutics, Inc. JUNO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q1
Sell
-550,000
Closed -$25.1M 58
2017
Q4
$25.1M Buy
550,000
+175,000
+47% +$8M 2.63% 8
2017
Q3
$16.8M Sell
375,000
-375,000
-50% -$16.8M 2.97% 11
2017
Q2
$22.4M Buy
750,000
+100,000
+15% +$2.99M 3.72% 7
2017
Q1
$14.4M Buy
+650,000
New +$14.4M 2.09% 17